194 related articles for article (PubMed ID: 9824673)
1. Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN).
Kotake Y; Sang H; Miyajima T; Wallis GL
Biochim Biophys Acta; 1998 Nov; 1448(1):77-84. PubMed ID: 9824673
[TBL] [Abstract][Full Text] [Related]
2. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
3. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.
Whan Han J; Gon Lee B; Kee Kim Y; Woo Yoon J; Kyoung Jin H; Hong S; Young Lee H; Ro Lee K; Woo Lee H
Br J Pharmacol; 2001 Jun; 133(4):503-12. PubMed ID: 11399667
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN).
Sang H; Wallis GL; Stewart CA; Kotake Y
Arch Biochem Biophys; 1999 Mar; 363(2):341-8. PubMed ID: 10068457
[TBL] [Abstract][Full Text] [Related]
5. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
Pieper GM; Nilakantan V; Zhou X; Khanna AK; Johnson CP; Roza AM; Adams MB; Hilton G; Felix CC
J Pharmacol Exp Ther; 2005 Feb; 312(2):774-9. PubMed ID: 15347735
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of Buthus martensi Karsch extracts on interleukin-1beta-induced expression of nitric oxide (NO) synthase and production of NO in human chondrocytes and LPS-induced NO and prostaglandin E2 production in mouse peritoneal macrophages.
Kim KS; Cho HS; Lee SD; Kim KH; Cho JY; Chung KH; Lee YC; Moon SK; Kim CH
Toxicol In Vitro; 2005 Sep; 19(6):757-69. PubMed ID: 15963682
[TBL] [Abstract][Full Text] [Related]
7. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide.
Connelly L; Palacios-Callender M; Ameixa C; Moncada S; Hobbs AJ
J Immunol; 2001 Mar; 166(6):3873-81. PubMed ID: 11238631
[TBL] [Abstract][Full Text] [Related]
8. Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice.
Miyajima T; Kotake Y
Biochem Biophys Res Commun; 1995 Oct; 215(1):114-21. PubMed ID: 7575577
[TBL] [Abstract][Full Text] [Related]
9. Optimal time and dosage of phenyl N-tert-butyl nitrone (PBN) for the inhibition of nitric oxide synthase induction in mice.
Miyajima T; Kotake Y
Free Radic Biol Med; 1997; 22(3):463-70. PubMed ID: 8981038
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation.
Lee AK; Sung SH; Kim YC; Kim SG
Br J Pharmacol; 2003 May; 139(1):11-20. PubMed ID: 12746218
[TBL] [Abstract][Full Text] [Related]
11. Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression.
Han M; Wen JK; Zheng B; Zhang DQ
Life Sci; 2004 Jun; 75(6):675-84. PubMed ID: 15172177
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
Kang JS; Jeon YJ; Kim HM; Han SH; Yang KH
J Pharmacol Exp Ther; 2002 Jul; 302(1):138-44. PubMed ID: 12065710
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the cytokine-mediated inducible nitric oxide synthase expression in rat insulinoma cells by phenyl N-tert-butylnitrone.
Tabatabaie T; Graham KL; Vasquez AM; Floyd RA; Kotake Y
Nitric Oxide; 2000 Apr; 4(2):157-67. PubMed ID: 10835296
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kappaB activation in RAW 264.7 cells.
Ahn KS; Noh EJ; Zhao HL; Jung SH; Kang SS; Kim YS
Life Sci; 2005 Apr; 76(20):2315-28. PubMed ID: 15748625
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.
Kobayashi O; Miwa H; Watanabe S; Tsujii M; Dubois RN; Sato N
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G688-96. PubMed ID: 11518681
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.
Heiss E; Herhaus C; Klimo K; Bartsch H; Gerhäuser C
J Biol Chem; 2001 Aug; 276(34):32008-15. PubMed ID: 11410599
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase expression by PPM-18, a novel anti-inflammatory agent, in vitro and in vivo.
Yu SM; Wu JF; Lin TL; Kuo SC
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):363-9. PubMed ID: 9371689
[TBL] [Abstract][Full Text] [Related]
19. Direct administration of interleukin-1 and interferon-gamma to rat pancreas leads to the in vivo production of nitric oxide and expression of inducible nitric oxide synthase and inducible cyclooxygenase.
Tabatabaie T; Vasquez AM; Moore DR; Floyd RA; Kotake Y
Pancreas; 2001 Oct; 23(3):316-22. PubMed ID: 11590329
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the expression of inducible nitric oxide synthase and cyclooxygenase-2 in macrophages by 7HQ derivatives: involvement of IkappaB-alpha stabilization.
Huang YC; Guh JH; Cheng ZJ; Chang YL; Hwang TL; Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 2001 Apr; 418(1-2):133-9. PubMed ID: 11334875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
